- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | COMVITA LIMITED: Comvita appoints Andrea Wilkins as Chief Marketing Officer | 1 | NZX | ||
| 23.02. | Comvita receives offshore interest for capital raise | 1 | Just Food | ||
| 23.02. | Comvita H1 FY26 slides: turnaround gains momentum, stock surges 17% | 2 | Investing.com | ||
| 22.02. | COMVITA LIMITED: CVT Delivers First-Half Priorities as Turnaround Continues | 1 | NZX | ||
| 18.02. | COMVITA LIMITED: Ongoing Disclosure Notice - Nigel Greenwood | - | NZX | ||
| 10.02. | COMVITA LIMITED: CVT half year results, call details for 23 February 2026 | 1 | NZX | ||
| COMVITA Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | COMVITA LIMITED: Comvita advises results of resolutions at Annual Meeting | 1 | NZX | ||
| 17.12.25 | COMVITA LIMITED: Comvita 2025 Annual Shareholders' Meeting | 1 | NZX | ||
| 12.12.25 | Comvita edges toward capital raise to support "recapitalisation" | 2 | Just Food | ||
| 11.12.25 | COMVITA LIMITED: Comvita reaches agreement with lending partners | 1 | NZX | ||
| 20.11.25 | COMVITA LIMITED: Comvita announces key leadership appointments | 2 | NZX | ||
| 20.11.25 | COMVITA LIMITED: SPH Notice - Florenz Limited, Dame Adrienne & Mark Stewart | 1 | NZX | ||
| 18.11.25 | COMVITA LIMITED: Notice of Annual Meeting | - | NZX | ||
| 17.11.25 | COMVITA LIMITED: Comvita announces change to Board of Directors | 1 | NZX | ||
| 17.11.25 | Comvita sale to Manuka honey peer Florenz falls through | - | Just Food | ||
| 16.11.25 | COMVITA LIMITED: Scheme resolution not passed. SIA terminated. | 1 | NZX | ||
| 14.11.25 | COMVITA LIMITED: Scheme Meeting address and presentation | 1 | NZX | ||
| 12.11.25 | COMVITA LIMITED: Scheme - Update on Voting Progress Ahead of Scheme Meeting | 2 | NZX | ||
| 11.11.25 | COMVITA LIMITED: Scheme of Arrangement - Further update on Voting | 2 | NZX | ||
| 10.11.25 | COMVITA LIMITED: Scheme of Arrangement - Update on Voting | - | NZX |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,190 | +0,88 % | DAX fester, Bitcoin tiefer: FMC, MTU, IBM, Telekom, Infineon, Airbus, SAP, Gerresheimer im ... | Der DAX hat am Montag Verluste einstecken müssen. Aus dem Handel ging er mit einem Minus von 1,1 Prozent bei 24.991,97 Punkten. Der Start in den Dienstag dürfte hingegen etwas freundlicher sein. Der... ► Artikel lesen | |
| FRESENIUS | 49,480 | -2,56 % | Fresenius: Das ist wichtig | Mit der Aktie von Fresenius ging es im heutigen Handel deutlich bergab. Dies lag vor allem am eher zurückhaltenden Ausblick der Tochter Fresenius Medical Care. Von Fresenius selbst gibt es am Tag vor... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,180 | -0,46 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| CLEARPOINT NEURO | 9,805 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| MIMEDX | 4,880 | -0,41 % | MiMedx Group, Inc: MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results | Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted... ► Artikel lesen | |
| BILLIONTOONE | 78,75 | +3,93 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
COMVITA LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu COMVITA LIMITED finden Sie auf Wallstreet Online.